Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Axogen, Inc.

AXGN Clue Score44
United States Fiscal year ends December CIK 0000805928 Results filed 28 Oct 2026

What the insiders did No buying or selling

By person

15 insiders · 0 transactions
4.0×

Michael Dale holds only 4.0 times base salary in stock. $3.16M of shares against $775.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Dale last reported holding, valued at $49.70, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Erick Wayne DeVinney
Chief Innovation Officer
—
—
—
262,781
$13.06M
+42.9%
Nir Naor
CFO
—
—
—
260,868
$12.96M
−13.0%
Amy McBride Wendell
Director
—
—
—
107,976
$5.37M
+4.9%
Doris Quackenbush
Sales VP
—
—
—
92,416
$4.59M
−4.0%
Guido J Neels
Director
—
—
—
86,743
$4.31M
−4.5%
Jens Kemp
Chief Marketing Officer
—
—
—
72,451
$3.60M
+125.6%
Lindsey Marie Hartley
CFO
—
—
—
65,146
$3.24M
+182.7%
Michael D Dale
Chief Executive Officer
—
—
—
63,537
$3.16M
—
Alan M Levine
Director
—
—
—
50,893
$2.53M
+24.7%
Marc A Began
EVP & General Counsel
—
—
—
50,135
$2.49M
—
Paul Thomas
Director
—
—
—
32,395
$1.61M
−7.2%
William P. Mr. Burke
Director
—
—
—
14,250
$708.18K
−63.0%
John Johnson
Director
—
—
—
14,150
$703.21K
−51.2%
Joseph A. Tyndall
Director
—
—
—
10,650
$529.27K
−57.5%
Kathy Johnson Weiler
Director
—
—
—
0
$0.00
−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.